New Device to Replace Aortic Valve in Patients Who Can't Have Open-Heart Surgery, University of California, Los Angeles (UCLA) Study

8/16/2012 7:51:16 AM

UCLA has performed its first transcatheter aortic valve replacement (TAVR), using a new device approved by the U.S. Food and Drug Administration to replace an aortic valve in a patient who was not a candidate for open-heart surgery. The procedure took place on Aug. 9. Ronald Reagan UCLA Medical Center is part of a growing trend of hospitals nationwide offering this new minimally invasive procedure.

Read at ScienceDaily

Read at Red Orbit

Read at News Release

Read at Zee News

Read at University of California Los Angeles

Read Article at

Related Companies

News Categories

• ScienceDaily

• Red Orbit

• News Release

• Zee News